Biotron Statistics

Total Valuation

Biotron has a market cap or net worth of AUD 8.11 million. The enterprise value is 6.46 million.

Market Cap	8.11M
Enterprise Value	6.46M

Important Dates

The last earnings date was Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Biotron has 2.70 billion shares outstanding. The number of shares has increased by 50.17% in one year.

Current Share Class	2.70B
Shares Outstanding	2.70B
Shares Change (YoY)	+50.17%
Shares Change (QoQ)	+10.51%
Owned by Insiders (%)	19.79%
Owned by Institutions (%)	0.43%
Float	2.00B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-9,338.25
PB Ratio	3.00
P/TBV Ratio	14.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.47

Current Ratio	1.47
Quick Ratio	1.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -122.62% and return on invested capital (ROIC) is -77.85%.

Return on Equity (ROE)	-122.62%
Return on Assets (ROA)	-50.99%
Return on Invested Capital (ROIC)	-77.85%
Return on Capital Employed (ROCE)	-72.88%
Weighted Average Cost of Capital (WACC)	0.07%
Revenue Per Employee	-289
Profits Per Employee	-645,390
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.00% in the last 52 weeks. The beta is -0.76, so Biotron's price volatility has been lower than the market average.

Beta (5Y)	-0.76
52-Week Price Change	-40.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.49
Average Volume (20 Days)	4,198,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotron had revenue of AUD -868 and -1.94 million in losses. Loss per share was -0.00.

Revenue	-868
Gross Profit	-868
Operating Income	-1.97M
Pretax Income	-1.94M
Net Income	-1.94M
EBITDA	-1.97M
EBIT	-1.97M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 1.64 million in cash and n/a in debt, with a net cash position of 1.64 million or 0.00 per share.

Cash & Cash Equivalents	1.64M
Total Debt	n/a
Net Cash	1.64M
Net Cash Per Share	0.00
Equity (Book Value)	2.70M
Book Value Per Share	0.00
Working Capital	544,562

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.92M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	226,598.16%
Pretax Margin	223,061.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biotron does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.17%
Shareholder Yield	-50.17%
Earnings Yield	-23.89%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotron has an Altman Z-Score of -20.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.26
Piotroski F-Score	1